etoposide has been researched along with isomethyleugenol in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Astaldi Ricotti, GC; Baas, F; Borst, P; de Haas, M; de Nooij, J; Eijdems, EW; Kamst, E; Timmerman, AJ; Van der Schans, GP | 1 |
Gonzalez, FJ; Korzekwa, KR; Nemec, J; Relling, MV; Schuetz, EG; Schuetz, JD | 1 |
Bertola, A; Boiocchi, M; Corona, G; Sorio, R; Toffoli, G | 1 |
Dai, Z; Ding, H; Druhan, LJ; Duan, W; Otterson, GA; Plass, C; Srinivasan, K; Villalona-Calero, MA; Yee, L; Zhu, WG | 1 |
Chen, CL; Chiang, CW; Jan, MS; Lin, CF; Lin, YS | 1 |
Chen, T; Hébert, J; Li, E; Richard, S; Yu, Z | 1 |
Brooks, CF; Croken, MM; Francia, ME; Gissot, M; Kim, K; Striepen, B | 1 |
Bártová, E; Fojtová, M; Jugová, A; Kozubek, S; Legartová, S; Lochmanová, G; Stixová, L; Zdráhal, Z | 1 |
Chiou, YY; Fu, SL; Lin, CH; Lin, WJ; Shih, IY; Weng, TH; Yang, JH | 1 |
Lau, W; Sattely, ES | 1 |
Clozel, T; Elemento, O; Erdem, Z; Hassler, MR; Krzywinski, M; Robinson, BD; Shariat, SF; Xylinas, E; Zhuang, D | 1 |
11 other study(ies) available for etoposide and isomethyleugenol
Article | Year |
---|---|
Reduced topoisomerase II activity in multidrug-resistant human non-small cell lung cancer cell lines.
Topics: Amsacrine; Carcinoma, Non-Small-Cell Lung; Cell Nucleus; DNA Damage; DNA Topoisomerases, Type II; Drug Resistance, Multiple; Etoposide; Humans; Lung Neoplasms; Methylation; RNA, Messenger; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1995 |
O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4.
Topics: Biotransformation; Catalysis; Catechols; Chromatography, High Pressure Liquid; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dexamethasone; Erythromycin; Etoposide; Humans; Methylation; Microsomes, Liver; Midazolam; Mixed Function Oxygenases; Teniposide | 1994 |
Reversal activity of cyclosporin A and its metabolites M1, M17 and M21 in multidrug-resistant cells.
Topics: Affinity Labels; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cell Membrane; Chromatography, High Pressure Liquid; Cyclosporine; Dihydropyridines; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Etoposide; Humans; Hydroxylation; Kinetics; Methylation; Molecular Structure; Paclitaxel; Photochemistry; Tumor Cells, Cultured | 1997 |
Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter.
Topics: Base Sequence; Binding Sites; Blotting, Northern; Cell Line; Cell Nucleus; Codon; CpG Islands; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Depsipeptides; DNA Methylation; Dose-Response Relationship, Drug; Etoposide; Flow Cytometry; Genes, p53; Humans; Immunoblotting; Luciferases; Lung; Methylation; Models, Genetic; Molecular Sequence Data; Mutation; Peptides; Peptides, Cyclic; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Binding; Sodium Oxybate; Transfection; Tumor Cells, Cultured | 2003 |
Lithium inhibits ceramide- and etoposide-induced protein phosphatase 2A methylation, Bcl-2 dephosphorylation, caspase-2 activation, and apoptosis.
Topics: Animals; Apoptosis; Caspase 2; Caspases; Cells, Cultured; Ceramides; Enzyme Activation; Etoposide; Lithium; Methylation; Mice; Phosphoprotein Phosphatases; Phosphorylation; Protein Phosphatase 2; Protein Subunits; Proto-Oncogene Proteins c-bcl-2 | 2006 |
A mouse PRMT1 null allele defines an essential role for arginine methylation in genome maintenance and cell proliferation.
Topics: Adaptor Proteins, Signal Transducing; Alleles; Animals; Arginine; Cell Proliferation; DNA; DNA Damage; DNA Repair Enzymes; DNA-Binding Proteins; Down-Regulation; Embryo, Mammalian; Etoposide; Female; Fibroblasts; Genome; Genomic Instability; Interphase; Methylation; Mice; Mice, Inbred C57BL; Mitosis; MRE11 Homologue Protein; Protein-Arginine N-Methyltransferases; Rad51 Recombinase; Radiation, Ionizing; RNA-Binding Proteins | 2009 |
Toxoplasma gondii sequesters centromeres to a specific nuclear region throughout the cell cycle.
Topics: Cell Cycle; Centromere; Chromatin Immunoprecipitation; Chromosome Breakage; Etoposide; Fluorescent Antibody Technique; Histones; Humans; Lysine; Methylation; Mitosis; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Toxoplasma | 2011 |
Epigenetic aspects of HP1 exchange kinetics in apoptotic chromatin.
Topics: Acetylation; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Adhesion; Cell Line, Tumor; Chromatin; Chromobox Protein Homolog 5; Chromosomal Proteins, Non-Histone; Epigenesis, Genetic; Etoposide; Fibroblasts; Histones; Humans; Kinetics; Methylation; Mice; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Recombinant Fusion Proteins; Signal Transduction; Tumor Suppressor Protein p53 | 2013 |
Arginine methylation of hnRNPK negatively modulates apoptosis upon DNA damage through local regulation of phosphorylation.
Topics: Apoptosis; Arginine; Caspase 3; Cell Line; DNA Damage; Etoposide; Heterogeneous-Nuclear Ribonucleoprotein K; Humans; Methylation; Mutation; Phosphorylation; Protein Kinase C-delta; Protein-Arginine N-Methyltransferases; Repressor Proteins; Ribonucleoproteins | 2014 |
Six enzymes from mayapple that complete the biosynthetic pathway to the etoposide aglycone.
Topics: Amino Acid Sequence; Biosynthetic Pathways; Etoposide; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Plant; Genetic Engineering; Methylation; Mixed Function Oxygenases; Molecular Sequence Data; Nicotiana; Podophyllotoxin; Podophyllum peltatum; Topoisomerase Inhibitors; Transcriptome | 2015 |
An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer.
Topics: Antineoplastic Agents; Azacitidine; Biomarkers, Tumor; Cell Line, Tumor; Cisplatin; Decitabine; Doxorubicin; Drug Resistance, Neoplasm; Epigenomics; Etoposide; Homeodomain Proteins; Humans; Hydroxamic Acids; Methylation; Neoadjuvant Therapy; Promoter Regions, Genetic; Urinary Bladder Neoplasms; Vinblastine; Vorinostat | 2016 |